These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5941685)

  • 21. [Serum and hepatic glutamic-oxalacetic and glutamic-pyruvic transaminase activity in experimental iron-deficiency anemia in guinea pigs].
    Bota V; Oşan A; Mathe I; Tambrea M
    Rev Med Chir Soc Med Nat Iasi; 1980; 84(3):509-13. PubMed ID: 7244476
    [No Abstract]   [Full Text] [Related]  

  • 22. [Metabolic disturbances in chronic diseases of the biliary tracts and liver].
    Kozlovskiĭ IV; Okorokov AN
    Vrach Delo; 1982 Aug; (8):22-4. PubMed ID: 6755904
    [No Abstract]   [Full Text] [Related]  

  • 23. [Significance of blood copper and iron relationship in the differential diagnosis of surgical diseases of the liver and biliary duct].
    Rill A; Aganović V; Nikolis P; Vujović B
    Med Arh; 1975; 29(4):287-9. PubMed ID: 1186313
    [No Abstract]   [Full Text] [Related]  

  • 24. [Letter: Caffeine in biliary and liver diseases].
    Zeller W
    Med Klin; 1975 Sep; 70(36):1441-2. PubMed ID: 1177798
    [No Abstract]   [Full Text] [Related]  

  • 25. Revisiting the topic of histochemically detectable copper in various liver diseases with special focus on venous outflow impairment.
    Mounajjed T; Oxentenko AS; Qureshi H; Smyrk TC
    Am J Clin Pathol; 2013 Jan; 139(1):79-86. PubMed ID: 23270902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Serum enzyme activity in liver and biliary tract diseases].
    Gerlach U
    Curr Probl Clin Biochem; 1968; 1():165-96. PubMed ID: 4950595
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum glutamic oxalacetic transaminase in diseases of the liver and biliary tract.
    MADSEN S; BANG NU; IVERSEN K
    Br Med J; 1958 Mar; 1(5070):543-6. PubMed ID: 13510721
    [No Abstract]   [Full Text] [Related]  

  • 28. [Disorders of protein metabolism in patients with surgical diseases of the liver and bile ducts].
    Borovkov SA; Tsubaka NIa
    Sov Med; 1968 Mar; 31(3):87-91. PubMed ID: 5674180
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies on srum glutamic pyruvic transaminase in health and in diseases of the liver.
    Pai ML
    Indian J Physiol Pharmacol; 1966 Jul; 10(3):93-103. PubMed ID: 5989227
    [No Abstract]   [Full Text] [Related]  

  • 30. [Activity of angiotensin converting enzyme I and levels of acid alpha glycoprotein in selected liver and biliary tract diseases].
    Podwysocki B; Simon K; Gładysz A
    Pol Tyg Lek; 1993 Mar 15-29; 48(11-13):268-70. PubMed ID: 8234040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Modifications of blood magnesium in some liver and biliary tract diseases of surgical interest].
    Zarrilli L; Maffettone F; Abate S
    Rass Int Clin Ter; 1971 Apr; 51(8):451-4. PubMed ID: 5087463
    [No Abstract]   [Full Text] [Related]  

  • 32. [Abnormalities of lipoprotein metabolism in hepatic and biliary diseases].
    Naito C
    Saishin Igaku; 1972 Mar; 27(3):515-23. PubMed ID: 5021396
    [No Abstract]   [Full Text] [Related]  

  • 33. [Disorders of sodium and potassium metabolism in liver diseases].
    Rudyk BI
    Vrach Delo; 1971 Nov; 11():102-5. PubMed ID: 4947073
    [No Abstract]   [Full Text] [Related]  

  • 34. [Evaluation of blood ammonia level in liver diseases].
    Engelmann L
    Z Gesamte Inn Med; 1970 Dec; 25(23):1049-55. PubMed ID: 4104436
    [No Abstract]   [Full Text] [Related]  

  • 35. [THE BEHAVIOR OF SERUM IRON AND SERUM COPPER IN DISEASES OF THE LIVER AND BILIARY TRACT COMPARED TO SOME ENZYME ACTIVITIES (GOT,GPT,AP) IN THE SERUM].
    GOEGGEL KH; EPPERLEIN H
    Acta Hepatosplenol; 1965; 12():141-57. PubMed ID: 14313166
    [No Abstract]   [Full Text] [Related]  

  • 36. [Characteristics of carbohydrate metabolism in children with chronic hepatobiliary system diseases].
    Smiian IS; Slobodian IM; Khodorchuk NIa; Babinets' TS
    Pediatr Akus Ginekol; 1975; (4):17-9. PubMed ID: 1064835
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative evaluation of the diagnostic importance of determining 5-nucleotidase and alkaline phosphatase in the blood serum in liver and biliary tract diseases].
    Terletskaia LM
    Vestn Khir Im I I Grek; 1981 Oct; 127(10):47-51. PubMed ID: 6274079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serum glutamate dehydrogenase in some diseases of the liver and the biliary tract].
    Jezek P; Ninger E; Vorácová A; Továrek J
    Vnitr Lek; 1968 Jul; 14(7):648-53. PubMed ID: 5683094
    [No Abstract]   [Full Text] [Related]  

  • 39. Bile acid metabolism in health and disease.
    Goldman MA; Schwartz CC; Swell L; Vlahcevic ZR
    Prog Liver Dis; 1979; 6():225-41. PubMed ID: 396557
    [No Abstract]   [Full Text] [Related]  

  • 40. [Higher fatty acids in liver and bile duct diseases in children].
    Alekseenko VP; Bliudzin IuA; Zviagina FE; Tarasova GG
    Vopr Okhr Materin Det; 1972 Oct; 17(10):28-32. PubMed ID: 4656405
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.